Yale Center for Immuno-Oncology Symposium

Please join us for a day-long Symposium featuring leaders in immunology from around the country for presentations, discussion, and networking.

Friday, October 11, 2019

Harkness Auditorium
333 Cedar Street, New Haven, CT
8:30am - 4:50pm

View the Full Agenda  

Thank you to our Symposium Sponsors:

Bristol-Myers Squibb 

Pfizer

Presentations

Opening remarks

Charles S. Fuchs, MD, MPH, Director, Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital

Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine; Interim Director of the Yale Center of Immuno-Oncology

David Schatz, PhD, Chair, Department of Immunobiology


Visualizing tumor immunity and response

Anna Wu, PhD, Professor and Chair, Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope

David Rimm, MD, PhD, Professor of Pathology and of Medicine, Yale School of Medicine 


Taming the tumor microenvironment ecosystem

Greg Delgoffe, PhD, Assistant Professor, Immunology, University of Pittsburgh

Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, Dermatology and Medicine (Medical Oncology), Yale School of Medicine


Improving therapeutic success   

Cornelia Trimble, MD, Professor of Gynecology and Obstetrics, Oncology and Pathology, Johns Hopkins School of Medicine

Katerina Politi, PhD, Associate Professor of Pathology, Yale Cancer Center

Developing novel and cell-based therapies

Drew Pardoll, MD, PhD, Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Abeloff Professor of Oncology, Johns Hopkins University

Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale Cancer Center

Closing

Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine; Interim Director of the Yale Center of Immuno-Oncology

David Schatz, PhD, Chair, Department of Immunobiology 


Accreditation: The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: The Yale School of Medicine designates this live activity for 6 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Target Audience: YCC members, Smilow faculty, YSM, Nursing, Public Health Students, Faculty  It is the policy of Yale School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating as speakers in these programs are required to disclose any relevant financial relationship(s) they (or spouse or partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. The Center for Continuing Medical Education will ensure that any conflicts of interest are resolved before the educational activity occurs. This course will fulfill the licensure requirement set forth by the State of Connecticut.